Results 211 to 220 of about 1,547,379 (334)
Pandemic treaty textual analysis: ethics and public health implications. [PDF]
Anderson EMR, Fenton E, Crump JA.
europepmc +1 more source
Abstract The development of anatomy has been marked by ethically questionable practices. This has been because the dissection of human bodies has always existed on the periphery of conventional society, necessitating a range of dubious ways of obtaining dead bodies for educational and research purposes.
David Gareth Jones
wiley +1 more source
Frontline practitioners' perspective of the implementation of child protection laws and prevention of violence against children in Maputo, Mozambique. [PDF]
Nhassengo S +5 more
europepmc +1 more source
Abstract A lack of minimum legal standards for body donation programs undermines recent strides by anatomy professionals to promote ethical best practices in the United States (US). In particular, the commercialization of the dead by nontransplant tissue banks poses a risk to the public trust in academic body donation programs.
Laura E. Johnson
wiley +1 more source
Thanabots—AI‐generated digital representations of deceased donors—could enhance anatomy education by linking medical history with anatomy and fostering humanistic engagement. However, their use poses ethical questions and carries psychological risks, including issues around consent, authenticity, and emotional harm.
Jon Cornwall, Sabine Hildebrandt
wiley +1 more source
The International Human Rights Law and Social Media Regulation
Damilola Eriife Iyiola
openalex +2 more sources
Abstract Biomass gasification technology has been extensively researched around the world; however, there is a need to evaluate the current research landscape and evolutionary direction of research in the broader context of energy transition. A systematic bibliometric analysis of the Web of Science database was performed for articles that fall within ...
Olasunkanmi Opeoluwa Adeoye +5 more
wiley +1 more source
Aims The Medicines and Healthcare products Regulatory Agency (MHRA) introduced a risk‐proportionate approach to assess clinical trial applications for authorisation in August 2023. This study evaluates the impact of this approach on the timelines for reviewing proposals.
Andrea Manfrin +6 more
wiley +1 more source
Pharmaceutical governance system for costly drugs through human rights due diligence.
Lemmens T +5 more
europepmc +1 more source

